Clinical Trial Update: JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial (JUBILEE) assessing insulin glargine (Lantus) in patients with Type 2 diabetes mellitus in Eastern populations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED